Induction of the TEAD Co-activator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer

Resistance to endocrine therapies (ET) is common in estrogen receptor (ER) positive breast cancer, and most relapsed patients die with ET-resistant disease. While genetic mutations provide explanations for some relapses, mechanisms of resistance remain undefined in many cases. Drug-induced epigeneti...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Res
Main Authors: Gemma, Carolina, Lai, Chun-Fui, Singh, Anup K, Belfiore, Antonino, Portman, Neil, Milioli, Heloisa Z, Periyasamy, Manikandan, Raafat, Sara, Nicholls, Alyssa J., Davies, Claire M, Patel, Naina R., Simmons, Georgia M., Fan, Hailing, Nguyen, Van T M, Magnani, Luca, Rakha, Emad, Martin, Lesley-Ann, Lim, Elgene, Coombes, R. Charles, Pruneri, Giancarlo, Buluwela, Laki, Ali, Simak
Format: Artigo
Jezik:Inglês
Izdano: 2024
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7616691/
https://ncbi.nlm.nih.gov/pubmed/39356622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-24-0013
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki